ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,677,000 | +11.7% | 409,037 | -2.8% | 0.00% | 0.0% |
| Q4 2021 | $1,502,000 | +64.9% | 420,840 | +68.2% | 0.00% | +50.0% |
| Q3 2021 | $911,000 | -27.3% | 250,255 | -12.9% | 0.00% | 0.0% |
| Q2 2021 | $1,253,000 | -39.1% | 287,367 | -42.6% | 0.00% | -33.3% |
| Q1 2021 | $2,058,000 | -25.2% | 500,720 | -27.4% | 0.00% | -40.0% |
| Q4 2020 | $2,751,000 | +39.9% | 689,592 | -5.3% | 0.01% | +66.7% |
| Q3 2020 | $1,967,000 | -16.0% | 728,568 | -14.4% | 0.00% | -25.0% |
| Q2 2020 | $2,341,000 | +926.8% | 851,303 | +780.3% | 0.00% | – |
| Q1 2020 | $228,000 | +1.8% | 96,706 | +102.7% | 0.00% | – |
| Q4 2019 | $224,000 | -0.9% | 47,711 | -29.3% | 0.00% | – |
| Q3 2019 | $226,000 | -0.9% | 67,503 | -2.6% | 0.00% | – |
| Q2 2019 | $228,000 | +8.6% | 69,293 | 0.0% | 0.00% | – |
| Q1 2019 | $210,000 | +45.8% | 69,293 | +30.7% | 0.00% | – |
| Q4 2018 | $144,000 | -24.2% | 53,034 | -6.2% | 0.00% | – |
| Q3 2018 | $190,000 | -5.5% | 56,512 | -27.6% | 0.00% | – |
| Q2 2018 | $201,000 | -19.3% | 78,041 | -31.0% | 0.00% | – |
| Q1 2018 | $249,000 | -27.2% | 113,106 | -34.2% | 0.00% | – |
| Q4 2017 | $342,000 | -28.3% | 171,839 | +16.8% | 0.00% | -100.0% |
| Q3 2017 | $477,000 | +544.6% | 147,094 | +430.4% | 0.00% | – |
| Q2 2014 | $74,000 | -77.4% | 27,731 | -70.4% | 0.00% | -100.0% |
| Q1 2014 | $328,000 | -21.7% | 93,631 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $419,000 | +10.3% | 93,631 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $380,000 | -2.6% | 93,631 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $390,000 | +9.2% | 93,631 | 0.0% | 0.00% | -50.0% |
| Q4 2012 | $357,000 | – | 93,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|